{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:37:32Z","timestamp":1788482252928,"version":"build-2803163510"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>\n                    <jats:bold>Introduction:<\/jats:bold>\n                    Metabolic deregulation, a hallmark of cancer, fuels cancer cell growth and metastasis. Phosphoserine phosphatase (PSPH), an enzyme of the serine metabolism pathway, has been shown to affect patients\u2019 prognosis in many cancers but its significance in neuroblastoma remains unknown. Here, we show that the functional role and potential mechanism of PSPH and it is correlated with survival of neuroblastoma patients.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Patients and Methods:<\/jats:bold>\n                    The TARGET dataset (n = 151) and our hospital-based cases (n = 55) were used for assessing the expression level of PSPH associated with survival in neuroblastoma patients, respectively. Then,\n                    <jats:italic>in vitro<\/jats:italic>\n                    experiments were performed to define the role of PSPH in neuroblastoma. The ESTIMATE and TIMER algorithms were utilized to examine the correlation between PSPH expression level and abundance of immune cells. Further, Kaplan-Meier survival analysis was performed to evaluate the effect of both PSPH and immune cells on patients\u2019 prognosis.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    High expression of PSPH was significantly associated with unfavorable overall survival (OS) and event-free survival (EFS) in both the TARGET dataset and our hospital-based cases, and was an independent predictor of OS (hazard ratio, 2.00; 95% confidence intervals, 1.21\u20133.30,\n                    <jats:italic>p<\/jats:italic>\n                    = 0.0067).\n                    <jats:italic>In vitro<\/jats:italic>\n                    experiments showed that high expression of PSPH significantly promoted cell growth and metastasis. Further, the ESTIMATE result suggested that high expression level of PSPH was negatively associated with low stromal and ESTIMATE score. Specifically, high PSPH expression was found to be negatively associated with CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cell, macrophages and neutrophils, which negatively affected survival of neuroblastoma patients (\n                    <jats:italic>p<\/jats:italic>\n                    &amp;lt; 0.0001,\n                    <jats:italic>p<\/jats:italic>\n                    = 0.0005, and\n                    <jats:italic>p<\/jats:italic>\n                    = 0.0004, respectively).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    These findings suggested that PSPH expression could be a promising indicator for prognosis and immunotherapy in neuroblastoma patients by potentially influencing infiltration levels of immune cells.\n                  <\/jats:p>","DOI":"10.3389\/fcell.2022.873710","type":"journal-article","created":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T16:19:53Z","timestamp":1661530793000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Phosphoserine phosphatase as an indicator for survival through potentially influencing the infiltration levels of immune cells in neuroblastoma"],"prefix":"10.3389","volume":"10","author":[{"given":"Liang","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Jun","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3389\/fonc.2012.00065","article-title":"Analysis of PSPHL as a candidate gene influencing the racial disparity in endometrial cancer","volume":"2","author":"Allard","year":"2012","journal-title":"Front. Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"E15","DOI":"10.3390\/medicina56010015","article-title":"Tumor microenvironment","volume":"56","author":"Arneth","year":"2019","journal-title":"Med. Kaunas."},{"key":"B3","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1200\/JCO.2011.40.9169","article-title":"Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma","volume":"30","author":"Asgharzadeh","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrc1014","article-title":"Neuroblastoma: Biological insights into a clinical enigma","volume":"3","author":"Brodeur","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1200\/JCO.2008.16.6785","article-title":"The international neuroblastoma risk group (INRG) classification system: An INRG task force report","volume":"27","author":"Cohn","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e173290","DOI":"10.1001\/jamaoncol.2017.3290","article-title":"Dose-response association of CD8+ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer","volume":"3","author":"Consortium","year":"2017","journal-title":"JAMA Oncol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10549-015-3474-4","article-title":"Race-associated biological differences among Luminal A breast tumors","volume":"152","author":"D'Arcy","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"key":"B8","doi-asserted-by":"publisher","first-page":"7315","DOI":"10.2147\/JIR.S341981","article-title":"CTLA4-Mediated immunosuppression in glioblastoma is associated with the infiltration of macrophages in the tumor microenvironment","volume":"14","author":"Guan","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s12967-020-02469-8","article-title":"Expression and clinical significance of LAG-3, FGL1, PD-L1 and CD8(+)T cells in hepatocellular carcinoma using multiplex quantitative analysis","volume":"18","author":"Guo","year":"2020","journal-title":"J. Transl. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"170183","DOI":"10.1038\/sdata.2017.183","article-title":"Corrigendum: Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines.","volume":"4","author":"Harenza","year":"2017","journal-title":"Sci. Data"},{"key":"B11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/cac2.12016","article-title":"Gene signatures associated with genomic aberrations predict prognosis in neuroblastoma","volume":"40","author":"He","year":"2020","journal-title":"Cancer Commun."},{"key":"B12","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","article-title":"The tumor microenvironment innately modulates cancer progression","volume":"79","author":"Hinshaw","year":"2019","journal-title":"Cancer Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/sj.bjc.6604256","article-title":"High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer","volume":"98","author":"Kim","year":"2008","journal-title":"Br. J. Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cmet.2018.12.015","article-title":"Beta cell dysfunction in type 2 diabetes: Drained of energy?","volume":"29","author":"Knudsen","year":"2019","journal-title":"Cell. Metab."},{"key":"B15","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13059-016-1028-7","article-title":"Comprehensive analyses of tumor immunity: Implications for cancer immunotherapy","volume":"17","author":"Li","year":"2016","journal-title":"Genome Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/cac2.12188","article-title":"Cellular and molecular mechanisms of perineural invasion of pancreatic ductal adenocarcinoma","volume":"41","author":"Li","year":"2021","journal-title":"Cancer Commun."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"Timer: A web server for comprehensive analysis of tumor-infiltrating immune cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.7150\/ijbs.29203","article-title":"PSPH mediates the metastasis and proliferation of non-small cell lung cancer through MAPK signaling pathways","volume":"15","author":"Liao","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(07)60983-0","article-title":"Neuroblastoma","volume":"369","author":"Maris","year":"2007","journal-title":"Lancet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1083\/jcb.201604085","article-title":"The importance of serine metabolism in cancer","volume":"214","author":"Mattaini","year":"2016","journal-title":"J. Cell. Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1038\/s41388-021-01683-y","article-title":"PSPH promotes melanoma growth and metastasis by metabolic deregulation-mediated transcriptional activation of NR4A1","volume":"40","author":"Rawat","year":"2021","journal-title":"Oncogene"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.21873\/anticanres.11574","article-title":"Phosphoserine phosphatase is a novel prognostic biomarker on chromosome 7 in colorectal cancer","volume":"37","author":"Sato","year":"2017","journal-title":"Anticancer Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/s41591-018-0078-7","article-title":"Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis","volume":"24","author":"Savas","year":"2018","journal-title":"Nat. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"101582","DOI":"10.1016\/j.smim.2021.101582","article-title":"The dual role of neutrophils in cancer","volume":"57","author":"Shaul","year":"2021","journal-title":"Semin. Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/cr.2015.33","article-title":"cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions","volume":"25","author":"Sun","year":"2015","journal-title":"Cell. Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12967-016-0915-8","article-title":"Expression of serine\/glycine metabolism-related proteins is different according to the thyroid cancer subtype","volume":"14","author":"Sun","year":"2016","journal-title":"J. Transl. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"5047","DOI":"10.1158\/0008-5472.CAN-21-0691","article-title":"Neuroblastoma formation requires unconventional CD4 T cells and arginase-1-dependent myeloid cells","volume":"81","author":"Van de Velde","year":"2021","journal-title":"Cancer Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1200\/JCO.2014.56.1621","article-title":"Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: A report from the international neuroblastoma risk group project","volume":"32","author":"Vo","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"4516","DOI":"10.1200\/JCO.2010.33.7741","article-title":"Eight-signature classifier for prediction of nasopharyngeal [corrected] carcinoma survival","volume":"29","author":"Wang","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"5673","DOI":"10.1158\/1078-0432.CCR-18-0599","article-title":"Clinically relevant cytotoxic immune cell signatures and clonal expansion of T-cell receptors in high-risk MYCN-not-amplified human neuroblastoma","volume":"24","author":"Wei","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1007\/s00262-021-03107-y","article-title":"the integration of systemic and tumor PD-L1 as a predictive biomarker of clinical outcomes in patients with advanced NSCLC treated with PD-(L)1blockade agents.","volume":"71","author":"Zamora Atenza","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1158\/1078-0432.CCR-15-1849","article-title":"Reversing T-cell dysfunction and exhaustion in cancer","volume":"22","author":"Zarour","year":"2016","journal-title":"Clin. Cancer Res."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2022.873710\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T16:20:03Z","timestamp":1661530803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2022.873710\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,26]]},"references-count":34,"alternative-id":["10.3389\/fcell.2022.873710"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2022.873710","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,26]]},"article-number":"873710"}}